Fill Finish
Delivering the services critical to your success – services to support new drug development, from technical/development batches, Phase I clinical trials through to product launch.
Our fill finish capabilities – Cambridge Pharma is a leading provider of CDMO services to support new drug development, from technical/ development batches, Phase I clinical trials through to product launch.
From our experienced team of experienced pharmaceutical specialists to our state-of-the-art facility, purpose-built to meet cGMP and MHRA standards, we are ideally placed to support these crucial stages of drug development.
We specialise in filling batches of 100 to 10,000 units for a range of presentations, including vials, syringes and cartridges as well as custom primary drug containers.
Our state-of-the-art cGMP facility is designed to provide the highest levels of sterility assurance and quality control. It’s equipped to work with small molecules, cytotoxic formulations and large molecules (non-active biologics), and can handle a wide range of solution viscosities, suspensions and gels.
Alongside our cGMP manufacturing facility, our pilot and analytical laboratories allow our experienced scientific team to carry out process development work, analytical method transfer and validation, QC release and stability testing, and, if required, QP release to clinic.
Services include:
- Analytical services
- Process development
- Sterile filling
- Cartridge filling
- Speciality filling
- Sterility assurance
- Syringe filling
- Vial filling